← SynDRA
AZAKENPAULLONE
SynDRA canonical compound SYN0004637 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CCNB1 | CDK1 | CDK5 | GSK3B |
|---|
| Mechanism of action | glycogen synthase kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- CDK1 INHIBITOR
- CDK5 INHIBITOR
- GSK3B INHIBITOR
- glycogen synthase kinase inhibitor
- CCNB1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- MARK2
- PAK4
- PAK1
- NTRK2
- NTRK1
- NEK2
- MET
- MARK3
- MAPKAPK3
- LCK
- MAPKAPK2
- MAPK9
- MAPK8
- MAPK13
- MAPK12
- MAPK1
- LYN
- PDPK1
- PIM1
- PIM2
- PLK1
- STK3
- SRC
- SGK2
- RPS6KB1
- RPS6KA3
- ROCK2
- ROCK1
- PRKD2
- PRKCZ
- PRKCG
- PRKCD
- PRKACA
- PRKAA1
- PLK4
- PLK3
- LIMK1
- KIT
- AKT1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CCNA1
- CCNA2
- CCNB2
- CCNB3
- CDK5R1
- COMT
- CSK21
- DYR1A
- GAMT
- GNMT
- HNMT
- NNMT
- NR1I3
- NSD2
- PNMT
- VGFR3
Cross-references
Synonyms
- 1-Azakenpaullone
- 9-bromo-7,12-dihydropyrido[3',2':2,3]azepino[4,5-b]indol-6(5H)-one
- C15H10BrN3O
- Kinome_3492
- 1-AKP
- SCHEMBL378920
- GTPL8018
- CHEMBL336961
- BDBM7497
- DTXSID8042686
- NOCAS_42686
- CTK8F0375
- MolPort-003-844-675
- CHEBI:131490
- HMS3653A17
- HMS3229B07
- BCP21061
- ZINC13588927
- s7193
- 2138AH
- 1-Azakenpaullone, >
- AKOS030240424
- SB19270
- TRA0006688
- NCGC00386322-01
- RT-006179
- FT-0662368
- SW220021-1
- KS-00001866
- RefChem:115934
- DTXCID6022686
- 1-Azakenpaullone (1-Akp)
- orb1300838
- SCHEMBL29363781
- GLXC-03321
- HMS3886N11
- 1-Azakenpaullone, >=97% (HPLC)
- CCG-267787
Look up AZAKENPAULLONE in the interactive SynDRA portal →